DRD2 and Parkinson disease: During age and basal ganglia injury, the progressive decline in DA targeting glial cells via DRD2 in VM and Str of aged MPTP‐treated PD mice was associated with decreased Wnt/β‐catenin signaling genes and proteins, in turn affecting both glial cell reactivity and mDAn loss (Marchetti, 2018).